A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07493135 · RECRUITING
Trial details
- NCT number
- NCT07493135
- Sponsor
- Suzhou Immunofoco Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2028-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.